HIF1A and cancer: 1,25(OH)2D3 has been stated to upregulates HIF-1α via mTOR signaling in human monocytes and breast epithelial cells [42, 43], while other studies uncovered that HIF-1α status is attenuated by 1,25(OH)2D3 treatment in human cancer cells [44].